Streetbeat News

Stock Prices

QLYS

Qualys, Inc. (NYSE:QLYS) has seen a 9.91% increase in its short percent of float since the last report, reaching 11.76% of all shares available for trading. With 3.79 million shares sold short, it would take about 7.49 days for traders to cover their short positions. This rise in short interest indicates a more bearish market sentiment towards QLYS, although it doesn't necessarily predict a price drop. Compared to its peers, Qualys has a significantly higher short interest, with the average for its peer group being 3.91%.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 5:15 pm

FG

F&G Annuities & Life (NYSE:FG) has seen a 29.66% increase in short interest since its last report, with 628 thousand shares sold short, representing 3.41% of its float. This indicates a bearish market sentiment, although it's higher than its peer group average of 2.59% short interest. The article suggests that while increased short interest can signal bearish sentiment, it can also present bullish opportunities under certain conditions.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 5:15 pm

USB

U.S. Bancorp's (NYSE:USB) short interest has increased by 17.5%, with 21.90 million shares sold short, representing 1.41% of its float. This indicates a bearish market sentiment, although it has less short interest compared to its peers' average of 1.70%. The rise in short interest doesn't necessarily predict a near-term price fall but suggests increased bearishness among traders.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 5:15 pm

VEEV

Veeva Systems Inc. shares are trading lower following the announcement of a CFO transition and the reiteration of its financial guidance.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 5:15 pm

GM

General Motors Co. (NYSE:GM) reported a 6% increase in retail sales year-over-year and delivered 594,233 vehicles in the U.S. in Q1 2024, a slight decrease of 1.5% due to lower fleet deliveries. GM maintained its leadership in key vehicle categories and is on track with its Ultium Platform EV production, including the Cadillac LYRIQ.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 5:08 pm

QDEL

QuidelOrtho Corporation (NASDAQ:QDEL) received FDA 510(k) clearance for its QuickVue COVID-19 test but announced the withdrawal of its FDA submission for the Savanna RVP4+ assay due to underperformance against clinical market expectations. Despite this, RBC Capital Markets maintains an Outperform rating and a price target of $81. QDEL shares dropped 10.6% to $42.

Portfolio Pulse from Vandana Singh

April 02, 2024 | 5:05 pm

DLTR

Dollar Tree (NASDAQ:DLTR) has received mixed analyst ratings over the past three months, with a total of 15 analysts offering their evaluations. The sentiment has shifted slightly towards a more cautious stance in the last 30 days. The average 12-month price target for DLTR has been adjusted to $159.33, up from $158.64, indicating a modest positive outlook. Analyst actions include both upgrades and downgrades, with price targets ranging from $144.00 to $180.00. Dollar Tree's financial performance shows positive revenue growth but challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 5:01 pm

SBUX

Starbucks (NASDAQ:SBUX) has seen significant bullish options activity, with 80% of traders showing bullish sentiment. The analysis of options history revealed 10 unusual trades, with a focus on a price window from $60.0 to $95.0. Notable trades include both puts and calls, with a bullish sentiment on puts being particularly interesting. Starbucks operates over 38,000 stores globally and is currently trading at $89.65, down by -2.06%. Analysts have set an average price target of $101.8, with varying ratings from Overweight to Market Perform.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 5:01 pm

COST

Recent options trading activity indicates a bearish stance on Costco Wholesale (NASDAQ:COST), with 76% of detected trades being bearish. The trading range for these options is between $585.0 and $755.0. Significant trades include both bullish and bearish sentiments, with notable trades aiming for strike prices from $670.00 to $735.00. Costco operates a membership-based retail model and is a major player in the warehouse club industry. Currently, COST's stock is slightly down at $720.3, with analysts giving mixed ratings but generally favoring a bullish outlook with target prices up to $870.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 5:01 pm

NRIX

Recent analyst ratings for Nurix Therapeutics (NASDAQ:NRIX) show a mix of bullish to bearish sentiments, with 5 bullish, 2 somewhat bullish, and 1 indifferent rating. The average 12-month price target is $24.38, slightly down from $24.40. Analyst actions include maintaining, raising, and lowering ratings and price targets, reflecting their current view on the company. Nurix Therapeutics, a biopharmaceutical company, focuses on novel treatments for cancer and immune disorders. Its financials show strong revenue growth and profitability, but challenges in ROE and ROA.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 5:00 pm